Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Concentrate solution for intravenous infusion: 215.2 mg/mL
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Cerebrolysin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
NoneCerebrolysin | 215.2 mg/mL Concentrate Solution for Intravenous InfusionAmber Glass Ampoule in 1 mL, 5 mL & 10 mL; Amber Glass Ampoule in 5 mL, 10 mL and 20 mL (Box of 10 ampoules); (box of 5 ampoules) | Rx | EVER Neuro Pharma GmbHAustria | Getz Bros. Philippines, Inc. | DR-XY35664 | Jan 20, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .